Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iodine-based radiopacity refers to the use of iodine-containing compounds as contrast agents in x-ray imaging to enhance the contrast between different tissues or structures by increasing x-ray attenuation in regions where they accumulate. Iodine's high atomic number (Z = 53) and k-edge energy (~33.2 keV) result in strong photoelectric absorption of x-rays, particularly at diagnostic radiology energies. While it provides high differential tissue contrast, its efficiency decreases at higher tube voltages compared to heavier elements. Safety concerns include hypersensitivity reactions and nephrotoxicity.
Photoelectric absorption enhanced by high-Z element (iodine); maximal near k-edge
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-ray attenuation via iodine-based radiopacity.